Background and Purpose: Recent prospective studies have explored the partial breast irradiation (PBI) for patients with early-stage breast cancer using different technical approaches. The purpose of this study is to explore feasibility, tumor control and acute and late toxicity of a specific hypo-fractionated 3D-CRT when treating postmenopausal pa-tients with early breast cancer with partial breast irradiation, using five fractions in five consecutive days. Materials and Methods: Ten patients, aged 70 underwent breast conservative surgery for invasive breast carcinoma with a complete microscopic resection; no lymphovascular invasion was found and negative axillary node status was assessed. Metal clips were positioned in the surgical bed at...
Purpose: Few definitive treatment options exist for elderly patients diagnosed with early stage brea...
Background and purpose: Randomized trials confirmed the efficacy and the safety of hypofractionated ...
The current standard therapeutic option for early stage breast cancer (EBC) employs a multimodality ...
AbstractBreast-conserving surgery including whole breast irradiation has long been a recommended pro...
© 2016 Elsevier Inc. Purpose Conventionally fractionated whole-breast irradiation (WBI) with a boost...
PURPOSE: To evaluate the efficacy and safety of hypofractionated whole-breast irradiation (HF-WBI) c...
Theodora A Koulis, Tien Phan, Ivo A Olivotto Department of Oncology, University of Calgary, Tom Bake...
Purpose: To reduce the fraction number in Partial Breast Irradiation (PBI) with initial prescription...
Abstract Purpose To assess toxicity and clinical outcome, in breast cancer patients treated with ext...
Partial breast irradiation (PBI) is an effective adjuvant treatment after breast conservative surger...
The aim of this study was to report 3-year outcomes of toxicity, cosmesis, and local control using a...
PURPOSE: Questions remain about whether moderately hypofractionated whole-breast irradiation is appr...
Objectives:The aim of this study is to evaluate the feasibility and the related toxicity of hypofrac...
Abstract Background Radiation therapy after lumpectomy is a standard part of breast conserving thera...
There is a sound empirical basis for hypofractionation in radiotherapy for breast cancer. This artic...
Purpose: Few definitive treatment options exist for elderly patients diagnosed with early stage brea...
Background and purpose: Randomized trials confirmed the efficacy and the safety of hypofractionated ...
The current standard therapeutic option for early stage breast cancer (EBC) employs a multimodality ...
AbstractBreast-conserving surgery including whole breast irradiation has long been a recommended pro...
© 2016 Elsevier Inc. Purpose Conventionally fractionated whole-breast irradiation (WBI) with a boost...
PURPOSE: To evaluate the efficacy and safety of hypofractionated whole-breast irradiation (HF-WBI) c...
Theodora A Koulis, Tien Phan, Ivo A Olivotto Department of Oncology, University of Calgary, Tom Bake...
Purpose: To reduce the fraction number in Partial Breast Irradiation (PBI) with initial prescription...
Abstract Purpose To assess toxicity and clinical outcome, in breast cancer patients treated with ext...
Partial breast irradiation (PBI) is an effective adjuvant treatment after breast conservative surger...
The aim of this study was to report 3-year outcomes of toxicity, cosmesis, and local control using a...
PURPOSE: Questions remain about whether moderately hypofractionated whole-breast irradiation is appr...
Objectives:The aim of this study is to evaluate the feasibility and the related toxicity of hypofrac...
Abstract Background Radiation therapy after lumpectomy is a standard part of breast conserving thera...
There is a sound empirical basis for hypofractionation in radiotherapy for breast cancer. This artic...
Purpose: Few definitive treatment options exist for elderly patients diagnosed with early stage brea...
Background and purpose: Randomized trials confirmed the efficacy and the safety of hypofractionated ...
The current standard therapeutic option for early stage breast cancer (EBC) employs a multimodality ...